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Abstract
Dose-response functions used in regulatory risk assessment are based on studies of whole 
organisms and fail to incorporate genetic and metabolomic data. Bayesian belief networks (BBNs) 
could provide a powerful framework for incorporating such data, but no prior research has 
examined this possibility. To address this gap, we develop a BBN-based model predicting 
birthweight at gestational age from arsenic exposure via drinking water and maternal metabolic 
indicators using a cohort of 200 pregnant women from an arsenic-endemic region of Mexico. We 
compare BBN predictions to those of prevailing slope-factor and reference-dose approaches. The 
BBN outperforms prevailing approaches in balancing false-positive and false-negative rates. 
Whereas the slope-factor approach had 2% sensitivity and 99% specificity and the reference-dose 
approach had 100% sensitivity and 0% specificity, the BBN's sensitivity and specificity were 71% 
and 30%, respectively. BBNs offer a promising opportunity to advance health risk assessment by 
incorporating modern genetic and metabolomic data.
INTRODUCTION
Every major new US environmental regulation must undergo cost-benefit analysis to 
establish whether anticipated public health and environmental gains outweigh regulatory 
costs.1 If costs outweigh benefits, the Office of Management and Budget may return the 
proposed regulation to the Environmental Protection Agency (EPA) for modification or 
withdrawal. 2,3 In order to predict health benefits, cost-benefit analysts rely on dose-
response functions. These functions predict the number of deaths and illnesses in a 
population exposed to contaminants. If dose-response functions are inaccurate, the resulting 
benefits estimates could be either too high, leading to inefficient regulations, or too low, 
leading to regulations insufficient to protect public health.
For most contaminants, dose-response functions used for regulatory impact analyses are 
based on decades-old data collected in studies of laboratory rodents or, in a few cases, 
human populations. 4,5 Dose-response functions for carcinogens assume a linear relationship 
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between contaminant exposure and the lifetime probability of cancer. That is, to predict 
cancer risks, analysts multiply the estimated exposure dose by a constant known as the 
“cancer slope factor.” For all regulations other than those involving ambient air quality, 
dose-response assessments for non-carcinogenic effects are categorical: if the exposure dose 
is above a threshold known as the reference dose (RfD), then the exposed individual is 
assumed to be at risk, while exposures below the RfD are assumed to pose zero risk. These 
prevailing dose-response functions fail to incorporate modern biomedical data that have 
arisen from new analytical technologies, such as methods for sequencing DNA, analyzing 
DNA expression, and characterizing metabolic profiles. In addition, the approaches used for 
cancer and non-cancer health outcomes are inconsistent (the latter assuming a categorical 
response with a threshold and the former assuming a linear, no-threshold response). Due to 
these and other concerns, Congress has held hearings on and called for National Research 
Council reviews of EPA's processes for developing dose-response functions,6 heightening 
the urgency of developing alternatives that can incorporate complex biomedical data while 
employing a consistent process for cancer and non-cancer risks.
We propose that Bayesian belief networks (BBNs) could provide a platform for developing 
dose-response functions that incorporate modern biomedical data. BBNs emerged from the 
artificial intelligence field in the 1980s as a means to support causal inference.7 Although 
ecologists have long used BBNs in resource management and risk assessment,8–11 to our 
knowledge BBNs have not been previously used in human health risk assessment for 
environmental regulatory applications. We demonstrate the development of a BBN-based 
dose-response model for analyzing the risk of lower birthweight for gestational age as a 
function of arsenic exposure via drinking water, metabolic data, and demographic factors. 
We parameterize and test our model using data from a cohort of 200 mothers and newborns 
in an arsenic-endemic region of Mexico. We compare the BBN's predictive capability to that 
of prevailing dose-response assessment methods.
MATERIALS AND METHODS
Maternal Birth Cohort
To compare a BBN-based dose-response assessment approach to the prevailing RfD and 
slope factor approaches, we used maternal health, demographic, environmental exposure, 
and birth outcome data from the Biomarkers of Exposure to Arsenic (BEAR) prospective 
pregnancy cohort.12 This cohort was recruited in 2011-2012 from Gomez Palacio, Mexico, 
where 400,000 people are exposed to high arsenic levels.13 Participant recruitment methods 
are described elsewhere.12
For each participant, social workers collected information on age, education, smoking and 
alcohol consumption behaviors during pregnancy, seafood consumption, and sources of 
drinking and cooking water. Attending physicians reported infant birthweights and 
gestational ages at delivery. Maternal urine samples collected at delivery were analyzed for 
total, inorganic, and methylated arsenic as described in Laine et al. (2015).14
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Birth Outcome Measure
Infants with birthweights below the 10th percentile for gestational age are typically classified 
as small for gestational age.15 We calculated the small-for-gestational age cutoff values 
using a World Health Organization tool.16 Using this definition, only 14 infants in the cohort 
were small for gestational age. Due to the small sample size, we developed dose-response 
models to predict the probability that the birthweight-to-gestational-age (BWGA) ratio was 
below the 25th percentile, an outcome that we designate as “lower BWGA.” Of the 200 
infants, 57 were designated as lower BWGA.
Reference Dose Approach
Current US environmental policies define the RfD for assessing noncancer risks as17
(1)
where NOAEL is the no observable adverse effects level (the largest dose at which no 
statistically significant effects are observed) and the UFs are uncertainty factors accounting 
for interspecies extrapolation, intra-species differences, and uncertainty sources. The current 
arsenic RfD, 0.3 μg arsenic/(kg body weight-day), was derived from 1968 data on 
hyperpigmentation and keratosis incidence in a Taiwanese population exposed to arsenic in 
drinking water.18 Because this RfD does not consider birth outcomes, we computed an RfD 
for the BEAR cohort using Equation 1. Consistent with the current RfD, we assumed 
UFinter=UFintra=1 and UFother=3.19 In addition, we compared the BBN-based approach with 
the current regulatory RfD. For both analyses, we assumed that pregnant women drink 0.872 
liters/day and weigh 75 kg.20 All women exposed at levels above the RfD were assumed to 
be at risk of delivering an infant with lower BWGA. Sensitivity and specificity were 
estimated by comparing the resulting assignment of risk status to the true birth outcome for 
each participant.
Slope Factor Approach
The current arsenic slope factor, 1,500 kg-day/μg, was developed from data collected in 
1968 and 1977 on skin cancer prevalence as a function of arsenic exposure in the previously 
mentioned arsenic-endemic region of Taiwan. Because this slope factor is not applicable for 
estimating adverse birth outcomes, we estimated a slope factor for lower BWGA risk using 
the BEAR cohort. Consistent with the general approach for estimating cancer risk slope 
factors, we computed a maximum likelihood estimator (using Stata) by regressing BWGA 
against inorganic arsenic exposure concentration in drinking water along with other 
covariates (total maternal urinary arsenicals, maternal urinary monomethylated arsenic, age, 
education, alcohol and seafood consumption during pregnancy, smoking during pregnancy, 
and infant gender). Covariates were chosen based on a prior BEAR cohort analysis.12 
BWGA and all covariates measured on continuous scales were treated as continuous. We 
tested sensitivity and specificity using via leave-one-out cross-validation: each cohort 
member was removed from the data set, a regression model was fitted to the remaining 199 
members, the model was used to predict BWGA for the corresponding test subject, and this 
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estimate was converted to an indicator of lower BWGA status and compared against the 
case's true status.
BBN Approach
A BBN that predicts lower BWGA from the same covariates used in the regression model 
for the slope factor analysis was constructed using BayesiaLab (Laval, France) software. To 
the explanatory variables in the regression model, we added urinary inorganic and 
dimethylated arsenic, which were excluded from the regression model due to 
multicollinearity. In brief, a BBN is a probabilistic model represented as a directed acyclic 
graph in which nodes are variables and edges represent causal dependencies.7,21 A fully 
parameterized BBN represents the joint probability distributions among the variables. Our 
team's biomedical experts developed the BBN structure based on known or suspected 
mechanisms through which ingested inorganic arsenic is converted to potentially hazardous 
arsenic metabolites. The BEAR cohort data were then used to parameterize the model. All 
BBN variables were discretized (Table S2). We calibrated the posterior probability threshold 
above which lower BWGA status is assigned to maximize sensitivity first and then 
specificity. Sensitivity and specificity were tested using a leave-one-out cross-validation 
approach, in which the BBN was fitted to 199 cases and its prediction of lower BWGA 
status in the remaining case was compared to the case's actual status.
RESULTS AND DISCUSSION
Fitted Models
To estimate an RfD relating lower BWGA risk to arsenic exposure, we divided the LOAEL 
in the BEAR cohort (0.461 μg/liter, the detection limit) by an uncertainty factor of three, 
resulting in an RfD of 0.00179 μg/kd-day. This estimated RfD is more than two orders of 
magnitude less than the current US regulatory RfD of 0.3 μg/kg-day, which is based on skin 
hyperpigmentation and keratosis.
To estimate a model consistent with the slope factor approach, we used a multivariate linear 
regression to predict BWGA from the inorganic arsenic concentration in drinking water and 
other covariates summarized in Table S1. Consistent with prior research on this cohort,12 the 
urinary concentration of monomethylated arsenic was highly significant (p=0.003), and the 
drinking water arsenic concentration was marginally significant (p=0.107) (Table S1).
We fitted a BBN model to predict lower BWGA status as a function of the same variables 
used in the regression model plus two additional descriptors of maternal arsenic metabolism 
(inorganic and dimethylated arsenic concentrations in urine) that could not be included in 
the regression model due to multicollinearity (Figure 1). A sensitivity analysis showed 
mother's age, infant gender, and urinary concentration of monometheylated arsenic have the 
greatest information value for predicting BWGA status (Figure S1).
Model Sensitivity and Specificity
The RfD derived from the BEAR cohort predicted that every infant was in the lower BWGA 
category. Sensitivity and specificity were therefore 100% and 0% (Figure 2). In contrast, 
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using EPA's current RfD (28.6 μg/L), sensitivity and specificity were 25%, and 73%, 
respectively (Figure 2). Therefore, the current RfD misclassified 75% of lower BWGA 
cases.
The slope factor approach also yielded skewed results. Though the data set contained 57 
lower BWGA cases, the regression predicted three such cases (and of these three, only one 
was an actual case). The corresponding sensitivity and specificity were 2% and 99%, 
respectively (Figure 2).
In contrast to the other methods, the BBN achieved a more even balance between sensitivity 
(71%) and specificity (30%; Figure 2).
As a sensitivity analysis of model performance, cross-validation was repeated with 10% of 
the data used as a testing set. The BBN model still outperformed the other methods in 
balancing sensitivity and specificity. The sensitivities of the RfD, regression, and BBN 
models were 100%, 2%, and 65%, respectively; specificities were 0%, 98%, and 29%.
Relevance
Accurate risk assessment requires methods that balance the public health costs of false 
negatives with the potential excess regulatory costs of false positives. As demonstrated, our 
BBN model outperformed the RfD and slope factor methods in balancing sensitivity and 
specificity when predicting lower birthweight risk as a function of inorganic arsenic 
exposure in water. Specifically, the BBN achieved higher sensitivity (71%) than the slope 
factor approach (2%) and higher specificity (30%) than the RfD approach (0%). 
Furthermore, unlike the RfD approach, the BBN also was able to incorporate data on 
maternal arsenic metabolism, thought to be an important factor in fetal risk.12 Unlike the 
slope factor model, the BBN included multiple, correlated measures of maternal 
metabolism.
We hypothesize that the BBN outperforms the conventional methods for several reasons. 
The binary RfD approach cannot account for covariates or metabolic factors affecting infant 
risk. While the regression model includes metabolic indicators and demographic variables, 
its ability to do so is limited by the requirement of independence among predictors, the 
assumed linear relationship between BWGA and predictors, and limited ability to detect 
complex interactions.22 The regression model's low R2 (0.122) indicates its limited 
predictive power. The BBN, in contrast, is distribution-free and can account for linear and 
nonlinear relationships (or even relationships that may have both linear and nonlinear 
regions) along with correlations and complex interactions among predictor variables.
Although this work represents the first comparison of BBN-based and prevailing methods 
for human health dose-response assessment in an environmental context, a number of 
previous studies have compared BBN performance to that of prevailing predictive methods. 
For example, multiple studies have explored the capability of BBNs to predict health 
outcomes under alternative medical treatment regimes.23–28 Similar to in our study, many of 
these studies found that BBNs outperformed conventional prognostic methods. As an 
example, Forsberg et al. (2011) demonstrated that a BBN outperformed conventional 
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approaches in estimating survival in patients with operable skeletal metastases.28 In 
addition, other studies of medical outcomes have compared the performance of BBNs to that 
of regression models and found BBN performance comparable to or better than that of 
regression approaches. As an example, Stojadinovic et al. found that a BBN for estimating 
healthcare outcomes in severely wounded veterans was comparable in predictive capability 
to a logistic regression model.25 Despite their comparable performance, the authors 
recommended use of the BBN over regression because it was able to reveal associations 
between factors that were not evident in the regression and because its intuitive graphical 
structure could help clinicians understand causes of alternative health outcomes. In addition 
to medical applications, applications in ecological risk assessment have demonstrated 
superior performance of BBNs in comparison to traditional methods. As an example, Walton 
and Meidinger (2006) found that a BBN method for classifying ecosystem types in mapping 
applications outperformed the prevailing approach, which was based on expert review of 
various ecosystem measures.29 This evidence suggests that BBNs deserve further 
consideration for dose-response modeling, due to both their intuitive structure and their 
powerful analytic capabilities.
The major limitation of this study is the small size of the data set. In addition, the newborns 
in this cohort were generally of healthy weight, perhaps due to the “Mexican paradox,” the 
tendency for Mexican newborns to be at lower risk for underweight birth than expected from 
demographic data.30 Nonetheless, our model was more effective than both prevailing 
methods in classifying cases according to lower BWGA status. Future research with larger 
cohorts and/or additional variables representing the mechanisms through which arsenic acts 
on BWGA should improve model performance.
We have demonstrated that a BBN model outperforms prevailing RfD and regression-based 
slope factor approaches in predicting birthweight outcomes from arsenic exposure and 
maternal metabolic data. The BBN achieves this superior performance by incorporating 
information in a nonlinear, nonparametric structure that offers greater freedom than 
traditional approaches. In addition, the organization of the BBN is visually intuitive: 
relationships between variables are mapped clearly, and the structure lends itself to the 
development of risk assessment tools that may be more user-friendly than those currently 
available. Unlike the separate RfD and slope factor approaches, the BBN model also offers a 
unified and consistent way of assessing both cancer and non-cancer risks. Perhaps most 
importantly, BBNs allow for the incorporation of modern biomedical data into dose-
response functions, offering a promising opportunity for advancing dose-response 
assessment and health environmental regulatory impact analysis.
Supplementary Material
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Figure 1. 
Bayesian belief network model for predicting the risk of lower birthweight for gestational 
age as a function of maternal arsenic exposure, arsenic metabolism, and behavioral and 
demographic factors. The lowest node predicts birthweight divided by gestational age 
(BWGA) as a function of all of the other variables in the network; the target symbol 
indicates that the lower BWGA node state is the outcome of interest. The corresponding 
belief bars show probabilities of lower BWGA (< 25th percentile), middle BWGA (25th–75th 
percentile), or higher BWGA (>75th percentile) conditional on baseline states of the other 
nodes. Underlying all nodes are conditional probability tables fitted to the data set used in 
this study. Updated predictions of BWGA can be obtained by specifying the state of any 
node or set of nodes, and by performing the necessary probability calculus. While a number 
of nodes influence BWGA directly, several others’ effects are mediated by intermediates. 
The choice of structure was made to elicit predictive power while also maintaining 
biological plausibility.
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Figure 2. 
Sensitivity and specificity of alternative dose-response functions for predicting lower 
birthweight for gestational age. RfD=reference dose; BBN=Bayesian belief network.
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